Comparing Ipilimumab vs Tafinlar
Ipilimumab |
Tafinlardabrafenib |
||||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Melanoma - Metastatic, Melanoma. ipilimumab may also be used for purposes not listed in this medication guide. |
Prescribed for Melanoma - Metastatic. Tafinlar may also be used for purposes not listed in this medication guide. |
||||||||
|
Prescription only |
Prescription only |
||||||||
Ratings & ReviewsRecent helpful reviews |
|||||||||
|
N/A |
9.0
|
||||||||
Drug Class |
|||||||||
Side Effects |
|||||||||
|
See the full ipilimumab side effects document. |
Common side effects include: squamous cell carcinoma, fever, and hyperglycemia. See the full Tafinlar side effects document. |
||||||||
Pricing and Coupons* Prices are without insurance |
|||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
||||||||
Generic Availability |
|||||||||
|
No |
No |
||||||||
Dosage Form(s) Available |
|||||||||
| N/A |
|
||||||||
Brand Names |
|||||||||
| Yervoy |
N/A |
||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
|||||||||
|
352.8 hours |
22 hours |
||||||||
CSA Schedule**View glossary of terms. |
|||||||||
|
N
Not a controlled drug
Is not subject to the Controlled Substances Act. |
N
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category |
|||||||||
|
C
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
D
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
||||||||
FDA Alerts |
|||||||||
|
N/A |
N/A |
||||||||
Drug Interactions |
|||||||||
|
A total of 138 drugs are known to interact with ipilimumab:
|
A total of 582 drugs are known to interact with Tafinlar:
|
||||||||
Alcohol/Food/Lifestyle Interactions |
|||||||||
|
No results found - however, this does not necessarily mean no warnings exist. Always consult with your doctor or pharmacist. |
|
||||||||
Disease Interactions |
|||||||||
First Approval Date |
|||||||||
|
N/A |
May 29, 2013 |
||||||||
WADA ClassView World Anti-Doping Agency classifications. |
|||||||||
|
N/A |
N/A |
||||||||
More Information |
|||||||||
Consumer Resources |
|||||||||
Professional Resources |
|||||||||
Related Treatment Guide |
|||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Disclaimer: This site is designed to offer information for general educational purposes only. The health information furnished on this site and the interactive responses are not intended to be professional advice and are not intended to replace personal consultation with a qualified physician, pharmacist, or other healthcare professional. You must always seek the advice of a professional for questions related to a disease, disease symptoms, and appropriate therapeutic treatments.
For Melanoma, Metastatic Have been on Dabrafenib and Mekinist combined for 2 weeks. Melanomas have reduced in size and blood test results were good. Hoping it continues but it is only early days for me. Nausea, pain, itchiness. Taking antihistamines. Melanomas in spine so pain expected.